Early research (Phase 1)Study completedNCT00000772
What this trial is testing
A Phase I Open-Label Study of the Safety, Tolerance, and Pharmacokinetic Interactions of Combination Didanosine and Ribavirin in HIV-Positive Individuals
Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 15